Aims and Scope of Journal of Autoimmunity
The Journal of Autoimmunity is a peer-reviewed medical journal covering research on all aspects of autoimmunity. It was established in 1988 and is published 8 times per year by Elsevier. The editors-in-chief are Yehuda Shoenfeld (Sheba Medical Center) and M. Eric Gershwin (University of California, Davis). According to the Journal Citation Reports, the journal has a 2016 impact factor of 7.641. Less
Key Metrics
CiteScore 

19.9
Eigenfactor 

0.01 - 0.05
Impact Factor 

10 - 15
SJR 

Q1Immunology

SNIP 

2.92
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Autoimmunity
Journal of Autoimmunity Journal Specifications
| Overview | |
| Publisher | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1988 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Autoimmunity ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Autoimmunity
Targeting autoreactive B cells in rheumatoid arthritis through MHC class I-presented BCR-derived neo-epitopes.
- 30 Jun 2026
- Journal of autoimmunity
Efficacy, safety, and tolerability of treatments for interstitial lung disease associated with rtoid arthritis: A systematic review and network meta-analysis.
- 20 Jun 2026
- Journal of autoimmunity
Celiac disease plasma cells recognize the active form of transglutaminase 2 with and without bound substrate.
- 18 Jun 2026
- Journal of autoimmunity
Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.
- 17 Jun 2026
- Journal of autoimmunity
Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillance.
- 11 Jun 2026
- Journal of autoimmunity
Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study.
- 1 Jun 2026
- Journal of autoimmunity
Targeting autoreactive B cells in rheumatoid arthritis through MHC class I-presented BCR-derived neo-epitopes.
- 30 Jun 2026
- Journal of autoimmunity
Efficacy, safety, and tolerability of treatments for interstitial lung disease associated with rtoid arthritis: A systematic review and network meta-analysis.
- 20 Jun 2026
- Journal of autoimmunity
Celiac disease plasma cells recognize the active form of transglutaminase 2 with and without bound substrate.
- 18 Jun 2026
- Journal of autoimmunity
Description and therapy of palmoplantar pustular psoriasis under IL-17A or dual IL-17A/F inhibition.
- 17 Jun 2026
- Journal of autoimmunity
Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillance.
- 11 Jun 2026
- Journal of autoimmunity
Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study.
- 1 Jun 2026
- Journal of autoimmunity